Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 99 | nsp6:D99Y; | CL-3d; |
| 250 | nsp6:E250-; | CL-3b;CL-3f; |
| 39 | nsp6:E39G; | CL-3e; |
| 39 | nsp6:E39K; | CL-3d; |
| 108 | nsp6:F108-; | CL-3e; |
| 108 | nsp6:F108V; | CL-1a_3d; |
| 184 | nsp6:F184-; | CL-3b;CL-3e;CL-3f; |
| 191 | nsp6:F191-; | CL-1b;CL-3c; |
| 200 | nsp6:F200-; | CL-3e; |
| 200 | nsp6:F200L; | CL-3e;CL-3f; |
| 201 | nsp6:F201L; | CL-5; |
| 216 | nsp6:F216C; | CL-3b; |
| 220 | nsp6:F220L; | CL-3c; |
| 220 | nsp6:F220V; | CL-3e; |
| 225 | nsp6:F225-; | CL-3b; |
| 225 | nsp6:F225I; | CL-3d; |
| 228 | nsp6:F228-; | CL-3c;CL-3e; |
| 228 | nsp6:F228L; | CL-2_3e; |
| 235 | nsp6:F235L; | CL-3e; |
| 269 | nsp6:F269L; | CL-1a_3c;CL-1b;CL-3b;CL-3e; |
| 35 | nsp6:F35L; | CL-3b;CL-3e; |
| 36 | nsp6:F36L; | CL-3c;CL-3e; |
| 36 | nsp6:F36V; | CL-1b; |
| 42 | nsp6:F42-; | CL-3b; |
| 55 | nsp6:F55C; | CL-3f; |
| 59 | nsp6:F59-; | CL-3e; |
| 70 | nsp6:F70-; | CL-3a; |
| 70 | nsp6:F70V; | CL-3f; |
| 81 | nsp6:F81L; | CL-3e; |
| 107 | nsp6:G107-; | CL-1a_3d;CL-3b;CL-3d;CL-3e; |
| 107 | nsp6:G107C; | CL-3c; |
| 135 | nsp6:G135-; | CL-3b;CL-3e; |
| 188 | nsp6:G188-; | CL-3b;CL-3d;CL-3e; |
| 188 | nsp6:G188S; | CL-1a;CL-1a_3d;CL-3c;CL-3d;CL-3e; |
| 204 | nsp6:G204-; | CL-2; |
| 218 | nsp6:G218-; | CL-3c; |
| 258 | nsp6:G258V; | CL-3c;CL-3e; |
| 277 | nsp6:G277-; | CL-3f;CL-5; |
| 279 | nsp6:G279-; | CL-3e; |
| 279 | nsp6:G279S; | CL-3d; |
| 9 | nsp6:G9-; | CL-3f; |
| 9 | nsp6:G9D; | CL-1a_3e; |
| 9 | nsp6:G9S; | CL-3b;CL-3c; |
| 11 | nsp6:H11D; | CL-3d; |
| 11 | nsp6:H11N; | CL-3d; |
| 11 | nsp6:H11Q; | CL-3b; |
| 64 | nsp6:H64N; | CL-3b; |
| 64 | nsp6:H64Q; | CL-3b; |
| 124 | nsp6:I124-; | CL-3b; |
| 124 | nsp6:I124M; | CL-3b; |
Page 330 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com